Market Cap 2.54B
Revenue (ttm) 125.81M
Net Income (ttm) -96.43M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -76.65%
Debt to Equity Ratio 0.00
Volume 4,838,274
Avg Vol 822,030
Day's Range N/A - N/A
Shares Out 85.16M
Stochastic %K 11%
Beta N/A
Analysts Strong Sell
Price Target $38.50

Company Profile

HeartFlow, Inc., a medical technology company, provides non-invasive solutions for diagnosing and managing coronary artery diseases worldwide. Its HeartFlow Platform uses AI and computational fluid dynamics to creates a personalized 3D model of a patient's heart from a single coronary computed tomography angiography, a specialized type of scan that provides detailed images of the heart's arteries. The company's platform provides insights on blood flow, stenosis, and plaque volume and composition...

Industry: Health Information Services
Sector: Healthcare
Phone: 650 241 1221
Address:
331 E. Evelyn Avenue, Mountain View, United States
StocktwitsNews
StocktwitsNews Feb. 4 at 9:54 AM
EXCLUSIVE: Aclarion CEO Looks To Bigger AI MedTech’s Playbook To Reverse Fortunes $ACON $HTFL https://stocktwits.com/news/equity/markets/exclusive-aclarion-ceo-looks-to-bigger-ai-medtech-playbook-to-reverse-fortunes/cZbSvrBR4ZX
0 · Reply
SovereignSigma
SovereignSigma Feb. 4 at 9:50 AM
$HTFL mortgage REIT, hybrid book
0 · Reply
BrightStars
BrightStars Jan. 26 at 4:50 PM
$BEAT $HTFL $MDT In the business it’s good to know others in the same businesses and it’s easier to do business with people you know. Humbarger has been doing this for a while. Excellent for fit for HeartBeam.
0 · Reply
RickahShay
RickahShay Jan. 26 at 12:59 PM
$BEAT Regarding the PR piece “HeartBeam Appoints Bryan Humbarger as Chief Commercial Officer” in Business wire, Jan 22, 2026 7:00 AM. Mr. Humbarger (rough and tumble unvetted online search): Bachelor of Science in Economics from the University of Delaware (1995 to 1999) Master of Leadership Development from Pennsylvania State University (2005–2008). • Sales positions at Medtronic (ticker: $MDT ) and Bioquell www.bioquell.com (LSE: BIOQ) • Vice President of Sales for North America at AliveCor and Heartflow (ticker: $HTFL ) • 2020 - July - hired by Eko www.ekohealth.com • 2022 - Co-founder and CEO of Ventru (TM), [Not listed on www.ventrumed.com website as a co-founder or CEO.] Appears in a news photograph dated September 27th, 2023 (see photo below). • 2024 - August - hired by Proprio www.propriovision.com • 2026 - January - joins Heartbeam NFA – DYODD - GLTA
0 · Reply
SuperGreenToday
SuperGreenToday Jan. 23 at 5:01 PM
$HTFL Share Price: $33.08 Contract Selected: Jul 17, 2026 $30 Calls Buy Zone: $4.76 – $5.88 Target Zone: $7.76 – $9.48 Potential Upside: 54% ROI Time to Expiration: 174 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
LuckEtradER
LuckEtradER Jan. 19 at 2:46 PM
$HTFL 👀
0 · Reply
jbukley
jbukley Jan. 17 at 10:02 PM
$HTFL Wow Billionaire Investor Chamath promoting HeartFlow! https://x.com/chamath/status/2012628964590727649?s=46&t=fdbZTWCm5L9IPzyGLHviDQ
1 · Reply
LuckEtradER
LuckEtradER Jan. 16 at 10:42 PM
$HTFL 👀
0 · Reply
Arctice
Arctice Jan. 12 at 3:42 AM
$HTFL Putting on watchlist, might enter after lock-up period ends
0 · Reply
charlottecorday
charlottecorday Jan. 6 at 3:33 PM
$HTFL Aetna is in … let’s go
0 · Reply
Latest News on HTFL
Heartflow Reports Third Quarter 2025 Financial Results

Nov 12, 2025, 4:01 PM EST - 2 months ago

Heartflow Reports Third Quarter 2025 Financial Results


Baron Technology Fund: AI Update

Nov 12, 2025, 4:19 AM EST - 3 months ago

Baron Technology Fund: AI Update

AMD AVGO NVDA ORCL


HeartFlow: Investors Put Their Heart In

Aug 10, 2025, 9:28 AM EDT - 6 months ago

HeartFlow: Investors Put Their Heart In


Medtech firm Heartflow gains 47% in solid Nasdaq debut

Aug 8, 2025, 1:05 PM EDT - 6 months ago

Medtech firm Heartflow gains 47% in solid Nasdaq debut


Medtech firm Heartflow raises $316.7 million in US IPO

Aug 7, 2025, 8:54 PM EDT - 6 months ago

Medtech firm Heartflow raises $316.7 million in US IPO


Heartflow Pursues IPO On Growing Revenue And High Operating Losses

Jul 21, 2025, 11:17 AM EDT - 7 months ago

Heartflow Pursues IPO On Growing Revenue And High Operating Losses


StocktwitsNews
StocktwitsNews Feb. 4 at 9:54 AM
EXCLUSIVE: Aclarion CEO Looks To Bigger AI MedTech’s Playbook To Reverse Fortunes $ACON $HTFL https://stocktwits.com/news/equity/markets/exclusive-aclarion-ceo-looks-to-bigger-ai-medtech-playbook-to-reverse-fortunes/cZbSvrBR4ZX
0 · Reply
SovereignSigma
SovereignSigma Feb. 4 at 9:50 AM
$HTFL mortgage REIT, hybrid book
0 · Reply
BrightStars
BrightStars Jan. 26 at 4:50 PM
$BEAT $HTFL $MDT In the business it’s good to know others in the same businesses and it’s easier to do business with people you know. Humbarger has been doing this for a while. Excellent for fit for HeartBeam.
0 · Reply
RickahShay
RickahShay Jan. 26 at 12:59 PM
$BEAT Regarding the PR piece “HeartBeam Appoints Bryan Humbarger as Chief Commercial Officer” in Business wire, Jan 22, 2026 7:00 AM. Mr. Humbarger (rough and tumble unvetted online search): Bachelor of Science in Economics from the University of Delaware (1995 to 1999) Master of Leadership Development from Pennsylvania State University (2005–2008). • Sales positions at Medtronic (ticker: $MDT ) and Bioquell www.bioquell.com (LSE: BIOQ) • Vice President of Sales for North America at AliveCor and Heartflow (ticker: $HTFL ) • 2020 - July - hired by Eko www.ekohealth.com • 2022 - Co-founder and CEO of Ventru (TM), [Not listed on www.ventrumed.com website as a co-founder or CEO.] Appears in a news photograph dated September 27th, 2023 (see photo below). • 2024 - August - hired by Proprio www.propriovision.com • 2026 - January - joins Heartbeam NFA – DYODD - GLTA
0 · Reply
SuperGreenToday
SuperGreenToday Jan. 23 at 5:01 PM
$HTFL Share Price: $33.08 Contract Selected: Jul 17, 2026 $30 Calls Buy Zone: $4.76 – $5.88 Target Zone: $7.76 – $9.48 Potential Upside: 54% ROI Time to Expiration: 174 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
LuckEtradER
LuckEtradER Jan. 19 at 2:46 PM
$HTFL 👀
0 · Reply
jbukley
jbukley Jan. 17 at 10:02 PM
$HTFL Wow Billionaire Investor Chamath promoting HeartFlow! https://x.com/chamath/status/2012628964590727649?s=46&t=fdbZTWCm5L9IPzyGLHviDQ
1 · Reply
LuckEtradER
LuckEtradER Jan. 16 at 10:42 PM
$HTFL 👀
0 · Reply
Arctice
Arctice Jan. 12 at 3:42 AM
$HTFL Putting on watchlist, might enter after lock-up period ends
0 · Reply
charlottecorday
charlottecorday Jan. 6 at 3:33 PM
$HTFL Aetna is in … let’s go
0 · Reply
MarketSignalMatrix
MarketSignalMatrix Dec. 27 at 7:31 AM
$HTFL Momentum persists only for businesses proving consistency quarter to quarter. Operational cadence needs to tighten meaningfully. Sustained improvement may validate the long‑term thesis. As performance stabilizes, the path forward can strengthen.
0 · Reply
charlottecorday
charlottecorday Dec. 18 at 10:47 AM
1 · Reply
BillionerOfKing
BillionerOfKing Dec. 11 at 10:48 PM
$HTFL Current Stock Price: $28.34
0 · Reply
jbukley
jbukley Dec. 8 at 1:45 AM
$HTFL https://www.linkedin.com/posts/heartflow-inc_hearthealth-communityhealth-activity-7402770391477510144-ML8m?utm_medium=ios_app&rcm=ACoAACSdkdcBKCvINyduLBtBsWUe8bt_7z8ToK0&utm_source=social_share_video_v2&utm_campaign=copy_link Wow! Steve Saxs longtime MLB player….another HeartFlow Life Saved
0 · Reply
LuckEtradER
LuckEtradER Nov. 19 at 7:17 PM
$HTFL Revenue — $46.3 million, up 41% year-over-year and beating analyst estimates of ~$42.8 million. • Gross margin — 76.5%. • GAAP net loss — $50.9 million (or -$1.04 per share), driven largely by one-time items: • $32.1 million non-cash charge from remeasurement of common stock warrant liability (tied to the company’s August 2025 IPO). • $6.4 million loss on debt extinguishment (from prepaying its term loan post-IPO). • Non-GAAP net loss — $13.2 million (or -$0.27 per share), an improvement from prior periods. • Full-year 2025 guidance — Revenue of $173–173.5 million (37.5–38% growth), which topped consensus estimates at the time. I still remain bullish on these guys and believe they get acquired in next 2-3 years max.
0 · Reply
NoFearHere
NoFearHere Nov. 15 at 10:58 PM
$HTFL REST=28.49+29.14+31.08 +33.15 @ 9dma +34.60 @ 50 dma +35.45 @ 20 dma
0 · Reply
NoFearHere
NoFearHere Nov. 15 at 10:55 PM
$HTFL 🤯🤯 NEW LOW First snapshot you would think hey that's a good earnings second snapshot the net operating loss was 50.5 Million 109% of total revenue LOL but compared to a year ago 39 million or 101% of Revenue so there's a glimmer of light in that pile of shit So there was great and then there was bad could be a nice opportunity to enter
0 · Reply
JarvisFlow
JarvisFlow Nov. 13 at 8:56 PM
Canaccord Genuity updates rating for HeartFlow ( $HTFL ) to Buy, target set at 39 → 40.
0 · Reply
JarvisFlow
JarvisFlow Nov. 13 at 6:44 PM
JP Morgan has adjusted their stance on HeartFlow ( $HTFL ), setting the rating to Overweight with a target price of 36 → 40.
0 · Reply
JarvisFlow
JarvisFlow Nov. 13 at 4:13 PM
Stifel has adjusted their stance on HeartFlow ( $HTFL ), setting the rating to Buy with a target price of 35 → 40.
0 · Reply
Helloa11
Helloa11 Nov. 13 at 2:58 PM
$HTFL BAD EARNINGS OR WHAT ?
0 · Reply
Sambong
Sambong Nov. 12 at 4:33 PM
$HTFL over 36 to 42
0 · Reply